Day: December 3, 2019

Company Continues to Expect Proposed Transaction to be Completed During First Quarter of Calendar 2020NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) — The Madison Square Garden Company (NYSE: MSG) today announced that it has filed a confidential initial Form 10 Registration Statement with the U.S. Securities and Exchange Commission (“SEC”) for the proposed spin-off of its entertainment business. The filing represents a significant milestone with regard to completing the transaction, which the Company continues to expect will take place in the first quarter of calendar 2020, subject to certain conditions.As previously announced, the proposed separation of the sports and entertainment business would be structured as a tax-free spin-off to all MSG shareholders.  Upon completion of the transaction, record holders of MSG common stock would...

NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it is now part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (“ARMI”). Headquartered in Manchester, New Hampshire, ARMI is the 12th Manufacturing USA Institute. ARMI brings together a consortium of over 100 partner organizations from industry, government, academia and the non-profit sector to develop next-generation manufacturing processes and technologies for cells, tissues and organs.Approximately $80 million from the federal government is being combined with more than $200 million in cost-share to support the development of tissue and organ manufacturing capabilities. As part of continuing efforts to help revitalize American manufacturing and incentivize companies to invest...

CYBER1 to explore achieving its US listing ambitions through a business combination with a Special Purpose Acquisition CompanyLondon United Kingdom – 03 December 2019, Cyber Security 1 AB (publ) (“CYBER1”), (Nasdaq:CYB1,OTCQX:CYBNY), a leading supplier of cyber security solutions with operations in Europe, Africa and the Middle East, announces today its intention to seek collaboration with a Special Purpose Acquisition Company (“SPAC”), as an effective means of achieving access to the US capital markets.As previously announced (press release accessible here), CYBER1 is exploring strategic alternatives to a listing in Sweden. CYBER1 and its advisors have identified the following to be the current viable options: a secondary public offering in the US market; upward progression of the CYBER1 American Depositary Receipt (OTCQX:...

Capital Increase Reserved for Employees of French companies participants in the employee stock ownership plansCharenton-le-Pont, France (December 3, 2019 – 6:30pm) – The purpose of this offer is to further engage EssilorLuxottica’s employees in the development of its business by allowing them to become shareholders of the Group.At the Extraordinary General Meeting on May 16, 2019, shareholders of EssilorLuxottica authorized the Board of Directors, within a 26-month period, to issue shares reserved for employees participating in an employee stock ownership plan, with new shares representing up to 0.5% of the total capital stock (Resolution 15).The Board of Directors decided the principle to issue up to 350,000 common shares reserved for participants in the EssilorLuxottica Group’s employee stock ownership plans and delegated to the Executive...

Augmentation de capital réservée aux salariés des sociétés françaises participantes au Plan d’Epargne EntrepriseCharenton-le-Pont, France (le 3 décembre 2019 – 18h30) – Cette opération a pour objectif d’engager les salariés d’EssilorLuxottica dans le développement de son activité en leur permettant de devenir actionnaires du Groupe.L’Assemblée Générale Extraordinaire des actionnaires de la société EssilorLuxottica du 16 mai 2019 a autorisé, pour une durée de 26 mois, le Conseil d’administration à procéder à l’émission d’actions réservée aux salariés adhérents à un Plan d’Epargne Entreprise, dans la limite de 0,5 % du capital (résolution n°15).Le Conseil d’administration a décidé du principe d’une augmentation de capital par émission d’un nombre maximal de 350 000 actions ordinaires dont la souscription est réservée aux salariés...

            Vectorio® is a set of Lipiodol® resistant medical devices (1) including syringes, patented stopcock and sampling devices. Vectorio® is dedicated for mixing and delivering Lipiodol® Ultra Fluid & anticancer drugs during cTACE procedure in adults with known, intermediate-stage hepatocellular carcinoma (HCC).HCC is the most common primary liver cancer and is the fourth biggest cause of death due to cancer worldwide (2).This medical device offers multiple advantages for healthcare professionals:24 hours Lipiodol® Ultra Fluid resistance (1). Patented 3-way stopcock with 4 connections offering possibility of “On-table mixing” (interventional radiologists have the possibility of remixing without disconnection from the micro-catheter, thus maximizing the safety during the intervention).Ready-to-use set: all devices in one set.User-friendly:...

DOVER, Del., Dec. 03, 2019 (GLOBE NEWSWIRE) — Pacific Green Technologies Inc. (PGTK or the “Company”) (OTCQB: PGTK), owner of the ENVI-Marine™ and ENVI-Clean™ Exhaust Gas Scrubbing Systems, today announced that Steven Matthew has been appointed Sales Director of its new Asia office located in Hong Kong. Steven will be focusing on marine technology and other areas of environmental technologies and will oversee the growth of the Asian business.Steven is a marine engineer, lawyer and commercial executive, experienced in the shipping and marine environmental fields. He’s been active in and around the marine and environmental technology sectors for nearly 30 years, working for companies such as Shell, Holman Fenwick Willan, Hyde Marine and ASP Ship Management.Scott Poulter, Pacific Green Technologies’ CEO said, “Steven is a fantastic...

http://guerbet.com/media/rqph4okn/vectorio.pngVectorio® est un kit unique de dispositifs médicaux (1) résistants au Lipiodol® Ultra Fluide comprenant des seringues, un robinet breveté et des systèmes de prélèvement. Vectorio® est destiné au mélange et à l’administration de Lipiodol® Ultra Fluide avec un produit anticancéreux au cours de procédures cTACE chez les adultes atteints de carcinome hépatocellulaire (CHC) au stade intermédiaire.Le CHC constitue la tumeur primaire du cancer du foie la plus commune et représente la quatrième cause de décès lié à un cancer dans le monde (2).Ce dispositif médical offre plusieurs avantages aux professionnels de santé :Une résistance de 24 heures au Lipiodol® Ultra Fluide (1).Un robinet breveté, trois voies et quatre connexions, offrant la possibilité d’un « mélange sur table » (les radiologues interventionnels...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.Regulatory release no. 35/2019Better Collective A/S (“Better Collective” or the “Company”), the world’s leading sports betting affiliate with a growing presence in the US, today announces its intention to carry out a directed share issue of approximately 4 million shares (the “Issue”) to a number of institutional investors.The transaction in briefBased on the authorisation granted by the annual general meeting on 25 April 2019, the Issue is being conducted through an accelerated bookbuilding process (the “Bookbuilding”), which will commence immediately following this...

Paris, December 3, 2019Availability of the offer circular drawn up by Iliad concerning the share buyback offer involving 11,666,666 Iliad shares for the purpose of reducing Iliad’s share capital  **Crédit Agricole Corporate & Investment Bank –  Société Généralefinancial advisors, presenting banks and guarantors for the buyback offerBNP PARIBAS Corporate & Institutional Banking  –  Natixisfinancial advisorsOFFER PRICE:€120 per Iliad shareDURATION OF THE OFFER:minimum of 20 calendar daysThis press release drawn up by Iliad is being published in compliance with Article 231-27, paragraphs 1 and 2, of the General Regulations of the French securities regulator – the Autorité des Marchés Financiers (“AMF“).In accordance with Article L.621-8 of the French Monetary and Financial Code (Code monétaire et financier)...